Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021


HomeEXECUTIVESBioretec appoints a Scientific Advisory Board with Leading International Pros in Traumatology and Orthopedics

Bioretec appoints a Scientific Advisory Board with Leading International Pros in Traumatology and Orthopedics

Bioretec Ltd, a Finnish biotechnology company developing bioabsorbable and bioresorbable implants for traumatology and orthopedic surgery, announced the establishment of a Scientific Advisory Board (SAB).

The SAB includes Prof. Dr. Klaus Dresing, Prof. Dr. Peter Giannoudis, Prof. Dr. Fan Liu, Prof. Dr. Rodrigo Pesantez, and Prof. Dr. Endre Varga. This professionally and academically distinguished group enables an efficient and comprehensive clinical development and evidence of our groundbreaking pipeline products to correspond to global customer needs with their decades of clinical experience from the field.

These honored experts will assist in opening up direct communication into surgeon communities allowing interactive knowledge transfer and sharing clinical experience.

”It is an honor to announce this SAB and integrate these merited leaders of the orthopedic industry with our new RemeOs™ Screw products and material technology development. We are thrilled to have decades of the expertise and impactful accomplishments of SAB members behind us. Their combined resume includes significant professional and academic contributions and influential positions in the global orthopedic community. We are looking forward to this cooperation with our SAB and interesting future activities,” said Timo Lehtonen, CEO of Bioretec.

Members of the Bioretec Scientific Advisory Board include:

Prof. Dr. Klaus Dresing has over 30 years of experience in trauma surgery and orthopedics. He has been the Chairman of the AO Alumni Association and a member of the AO Trauma International Board with various other positions in AO, AO Trauma, and AO Faculty Education Program. In addition, he is the Head and speaker of the German Society for Orthopedics and Trauma Surgery (DGOU) Guidelines Commission and a reviewer in multiple respected orthopedic journals.

Prof. Dr. Peter Giannoudis is a Professor and Chairman of Trauma & Orthopedics, School of Medicine in the University of Leeds. He is an Executive Board Member of EFORT Trauma Task Force, President of ESTROT, and Chair of AO Foundation´s Davos Courses. He has been the President of the British Trauma Society and Chair of the International Committee of Orthopedic Trauma Association (OTA). He has received 20 visiting professorship invitations, almost 700 publications in peer-reviewed journals, and 12 books.

Prof. Dr. Fan Liu has 40 years of experience from surgical trauma and is working currently as Vice President and as Chief and Professor in the Department of Orthopedic Surgery at the Affiliated Hospital to Nantong University. Prof. Dr. Liu is the Vice President of the Chinese Orthopedic Association and the Chinese Association of Orthopedic Surgeons. He is an editor in a number of orthopedic journals and a globally awarded scientific researcher.

Prof. Dr. Endre Varga is the Professor and Head of Trauma Department in Szeged, Hungary. He is the founder of ATLS European Committee and Past President of the Hungarian Trauma Society, Senior AO Trustee, and Honorary President of the AO Trauma Hungarian Chapter. He has done research in bioabsorbable materials with 92 scientific publications/book chapters. Prof. Dr. Varga is also a corresponding (honorary) member of DGU (Deutsche Gesellschaft fûr Unfallchirurgie).

Prof. Dr. Rodrigo Pesantez is the current Chairperson of AO Trauma Latin America (AOTLA). President of the Trauma in the Colombian Orthopedic Society and trustee of the AO Foundation, and director in multiple AO Trauma courses worldwide. He is an orthopedic trauma surgeon specialized in hip, trauma, and reconstruction. He has published multiple articles in peer-reviewed journals and written and edited orthopedic books.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy